Extended-Interval Immunotherapy in Advanced Lung Cancer: A Case Report

Salome Kordzaia1, Lasha Khmaladze1, Elene Dolmazashvili1

  • 1Medical Oncology, Multiprofile Clinic Consilium Medulla Ltd, Tbilisi, GEO.

Cureus
|April 10, 2026
PubMed
Summary

A modified immunotherapy schedule of every six weeks may stabilize advanced lung adenocarcinoma with brain metastases, potentially reducing toxicities. This approach warrants further clinical trial evaluation for broader applicability.

Related Concept Videos